Holen Sie sich die Stockscreener-App
15.04
3.65%
-0.57
Handel nachbörslich:
15.14
0.10
+0.66%
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-08-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
71.99%
13.58
|
7.894 | 44.06 | 18.45 | 12.59 |
Operating Expenses
|
2.63%
96.67
|
99.28 | 92.38 | 81.32 | 67.20 |
| Benefits Costs and Expenses |
2.67%
91.80
|
94.31 | 86.76 | 74.80 | 61.46 |
| Costs And Expenses |
2.67%
91.80
|
94.31 | 86.76 | 74.80 | 61.46 |
| Depreciation and Amortization |
4.54%
2.12
|
2.028 | 2.242 | 2.35 | 2.394 |
| Operating Income/Loss |
9.07%
-83.09
|
-91.39 | -48.32 | -62.86 | -54.61 |
| Income/Loss From Continuing Operations Before Tax |
9.49%
-78.22
|
-86.42 | -42.70 | -56.35 | -48.87 |
| Income Tax Expense/Benefit |
-
|
- | 0.76 | - | 0.082 |
| Income/Loss From Continuing Operations After Tax |
9.49%
-78.22
|
-86.42 | -43.46 | -56.35 | -48.96 |
|
Net Income/Loss
|
9.49%
-78.22
|
-86.42 | -43.46 | -56.35 | -48.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
96.68%
2.7974
|
84.16 | 83.88 | 83.56 | 72.78 |
| Diluted Average Shares |
96.68%
2.7974
|
84.16 | 83.88 | 83.56 | 72.78 |
| Basic Earnings Per Share |
19.42%
-0.83
|
-1.03 | -0.52 | -0.67 | -0.67 |
| Diluted Earnings Per Share |
19.42%
-0.83
|
-1.03 | -0.52 | -0.67 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):